Insider Buy Signals Tarsus Pharma’s Blepharitis Breakthrough Potential
Insightful insider activity at Tarsus Pharmaceuticals signals confidence in its ocular therapeutics pipeline and market strategy, yet highlights liquidity and valuation cautions for investors.
4 minutes to read